Gynecomastia in HIV-infected patients receiving antiretroviral therapy

被引:10
|
作者
García-Benayas, T [1 ]
Blanco, F [1 ]
Martín-Carbonero, L [1 ]
Valencia, E [1 ]
Barrios, A [1 ]
González-Lahoz, J [1 ]
Soriano, V [1 ]
机构
[1] Hosp Carlos III, Inst Salud Carlos III, Infect Dis Serv, Madrid 28035, Spain
关键词
D O I
10.1089/088922203769232539
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Thirty-four HIV-positive men with gynecomastia were seen in an HIV outclinic during a 20-month period (incidence of 2.4 cases/100 patients receiving HAART per year). It developed mainly in subjects having good immunologic and virologic status, after an average of 3 years of HAART. No hormone abnormalities were found, or association with specific drugs. Although initially unilateral, more than half of cases progressed to bilateral gynecomastia. Spontaneous resolution occurred in most subjects with 12 months without modifying therapy.
引用
收藏
页码:739 / 741
页数:3
相关论文
共 50 条
  • [1] Metabolic disorders in HIV-infected patients receiving antiretroviral therapy
    Kanestri, V.
    Kravchenko, A.
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2018, 21
  • [2] Diabetes mellitus in HIV-infected patients receiving antiretroviral therapy
    Moyo, D.
    Tanthuma, G.
    Mushisha, O.
    Kwadiba, G.
    Chikuse, F.
    Cary, M. S.
    Steenhoff, A. P.
    Reid, M. J. A.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2014, 104 (01): : 37 - 39
  • [3] Management of dyslipidaemia in HIV-infected patients receiving antiretroviral therapy
    Martínez, E
    Tuset, M
    Milinkovic, A
    Miró, JM
    Gatell, JM
    [J]. ANTIVIRAL THERAPY, 2004, 9 (05) : 649 - 663
  • [4] Nitric oxide levels in HIV-infected, untreated patients and HIV-infected patients receiving antiretroviral therapy
    Soccal, Renata Mezomo
    Mainardi de Carvalho, Jose Antonio
    Bochi, Guilherme Vargas
    Moresco, Rafael Noal
    Paz da Silva, Jose Edson
    [J]. BIOMEDICINE & PHARMACOTHERAPY, 2016, 79 : 302 - 307
  • [5] QT Dispersion in HIV-Infected Patients Receiving Combined Antiretroviral Therapy
    Wongcharoen, Wanwarang
    Suaklin, Somkhuan
    Tantisirivit, Nualnit
    Phrommintikul, Arintaya
    Chattipakorn, Nipon
    [J]. ANNALS OF NONINVASIVE ELECTROCARDIOLOGY, 2014, 19 (06) : 561 - 566
  • [6] Hypertension in HIV-Infected Patients Receiving Antiretroviral Therapy in Northeast Ethiopia
    Fiseha, Temesgen
    Belete, Alemu Gedefie
    Dereje, Henok
    Dires, Abebe
    [J]. INTERNATIONAL JOURNAL OF HYPERTENSION, 2019, 2019
  • [7] Hyperlactataemia and lactic acidosis in HIV-infected patients receiving antiretroviral therapy
    Calza, L
    Manfredi, R
    Chiodo, F
    [J]. CLINICAL NUTRITION, 2005, 24 (01) : 5 - 15
  • [8] Sustained Viral Suppression in HIV-Infected Patients Receiving Antiretroviral Therapy
    Yehia, Baligh R.
    Fleishman, John A.
    Metlay, Joshua P.
    Moore, Richard D.
    Gebo, Kelly A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2012, 308 (04): : 339 - 342
  • [9] Anemia in HIV-infected patients receiving highly active antiretroviral therapy
    Moore, RD
    Forney, D
    [J]. JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 29 (01): : 54 - 57
  • [10] Antiretroviral therapy of HIV-infected patients
    Gölz, J
    [J]. MEDIZINISCHE WELT, 1999, 50 (06): : 223 - 229